Prerpints.org logo
Preprint
Article

Orthologs of NOX5 and EC-SOD/SOD3: dNox and dSod3 Impact Egg Hardening Process and Egg Laying in Reproductive Function of Drosophila melanogaster

Altmetrics

Downloads

63

Views

38

Comments

0

A peer-reviewed article of this preprint also exists.

supplementary.zip (2.58MB )

Submitted:

23 April 2024

Posted:

24 April 2024

You are already at the latest version

Alerts
Abstract
The occurrence of ovarian dysfunction is often due to the imbalance between the formation of reactive oxygen species (ROS) and the (in)effectiveness of the antioxidative defense mechanisms. Primary sources of ROS are the respiratory electron transfer and the activity of NADPH oxidases (NOX), while Superoxide dismutases (SOD) are the main key reg-ulators that control the levels of ROS and reactive nitrogen species intra- and extracel-lularly. Because of their central role, SODs are the subject of research on human ovarian dysfunction, but the sample acquisition is low. The high degree of cellular and molecular similarity between Drosophila melanogaster ovaries and human ovaries provides this model organism with the best conditions for analyzing the role of ROS during ovarian function. In this study, we clarify the localization of the ROS producing enzyme dNox within ovaries of Drosophila melanogaster and by a tissue specific knockdown, we show that dNox derived ROS are involved in the chorion hardening process. Furthermore, we analyze the dSod3 localization and show that reduced activity of dSod3 impacts egg laying behavior, but not the chorion hardening process.
Keywords: 
Subject: Biology and Life Sciences  -   Cell and Developmental Biology

1. Introduction

Reactive oxygen species (ROS) is used as a collective term for byproducts that arise from the incomplete reduction of molecular oxygen (O2) during normal aerobic metabolism. Free radicals such as hydroxyl (OH●) and superoxide anion (O2●-), are highly reactive and can cause damage to proteins, DNA and lipids. Therefore, it is essential to keep the formation and elimination of ROS under control to maintain physiological metabolic functions. Antioxidative scavenging mechanisms counteract the production of ROS to prevent excessive ROS production.
On the other hand, superoxide anions and the non-radical hydrogen peroxide (H2O2) can act as signaling molecules or effectors within and between cells [1,2,3,4]. In the female reproductive system, ROS and antioxidants are considered key factors in the physiological metabolism of the ovary, as they have been shown to influence the reproductive processes of female mammals, such as folliculogenesis, ovulation, fertilization, corpus luteum maintenance/regression and embryogenesis [5,6,7,8,9].
Sources of ROS in the ovary can be macrophages and neutrophils, steroidogenic cells, and intracellular sites of origin such as mitochondria, endoplasmic reticulum, nuclear membrane electron transport and plasma membranes (as reviewed in [5]). To maintain the delicate redox balance, an antioxidant defense system composed of enzymatic and non-enzymatic antioxidants ensures the ovarian homeostasis (reviewed in [8]). Enzymatic antioxidants such as superoxide dismutase (SOD), catalase, glutathione peroxidase, glutathione reductase and glutathione oxidase are abundant in regions of ROS production within a cell. The most harmful ROS, superoxide anion, is removed by SOD in a dismutation reaction. However, SODs not only act as antioxidants that protect the cell from oxidative damage caused by ROS, they can also be considered as regulators that can convert one oxidant into another type of oxidant, thereby potentially affecting redox-dependent signaling pathways [10].
The SOD protein family in mammals consists of three members (SOD1–3) encoded by different genes. Exhibiting functional similarities, all forms of SOD catalyze the dismutation of superoxide to hydrogen peroxide, but differ in subcellular compartmentalization and cofactor requirements [11,12] and they require catalytic metal for their activation, the cytoplasmatic Cu/Zn-SOD (SOD1), the mitochondrial Mn-SOD (SOD2) and the extracellular Cu/Zn-SOD (SOD3 or EC-SOD) [12,13,14]. Being secreted extracellularly, SOD3 is the only enzyme able to remove superoxide from the extracellular space, protecting constituents in this compartment from oxidative modifications. Otherwise, the extracellular activity of SOD3 can be seen as a source of hydrogen peroxide for potential autocrine or paracrine redox signaling.
As SOD abundance and activity changes with female age and in ovarian dysfunctions, such as endometriosis and polycystic ovary disease (PCOS) [7,15,16,17], it is under research to become a potential biomarker determining systemic oxidative stress and oocyte quality [15,16]. However, due to limited options for obtaining suitable sample materials, there is a demand for investigations using alternative model organisms. Despite some obvious differences, Drosophila and mammalian ovaries have similarities regarding cellular organization and oocyte development, as reviewed in [18]. Concerning both organisms, conserved biological functions, including (inter)cellular signaling, must occur in the ovaries for functional female gametes to be produced. Therefore, analyzing the physiological regulation of ROS in Drosophila ovaries can provide important insights.
In Drosophila, three genes encode dSod (dSod1–3) [19,20]. The cytoplasmatic Cu/Zn-dSod (dSod1) (CG11793) [21], mitochondrial Mn-dSod (dSod2) (CG8905) [22,23] and the extracellular Cu/Zn-dSod (dSod3/EC-Sod3) (CG9027) [24,25]. The dSod3 exists in two isoforms, in addition to the extracellular form a membrane associated form is predicted [25].
Few is known about the function or localization of dSod3. The expression rate of dsod3 was previously shown to be higher in female compared to male flies [24,25], and the mRNA signal is elevated in ovaries [26], indicating a possible significant function of dSod3 during ovarian processes. Furthermore, using RNASeq, it has been shown that dSod3 is enriched in late-stage egg chambers [27]. The observation of an overexpressed dSod3-HA construct being secreted to the extracellular space of posterior mature follicle cells led to the assumption of a potential extracellular localization of dSod3 in the ovaries [28].
The substrate for extracellular SODs, superoxide anions, are formed enzymatically by NADPH oxidases (Nox). In Drosophila two members of the NOX family of proteins exist, dNox (CG34399) and dDuox (CG3131) [20], while there are seven members in the mammalian (NOX1 –5, DUOX1 and DUOX2) [29,30,31]. The dNox, orthologue to the human NOX5, is a protein with 6 transmembrane domains that contains an EF-hand-containing calcium-binding domain that mediates activation by cytosolic calcium and a cytoplasmic NADPH-binding site, reviewed in [32,33].
ROS produced by Drosophila dNox have been shown to be essential in the ovulation process to control agonist-induced calcium flux during ovarian smooth muscle contraction [34] and for a successful follicle rupture, as has been shown previously during an ex vivo assay of dissected late-stage egg chambers [28]. According to these studies, dNox primarily produces superoxide anions (O2●-) to the extracellular space, which dismutate spontaneously or are dismutated enzymatically by extracellular superoxide dismutase (dSod3) [28,34]. Using RNASeq, dNox has been shown to be enriched in late-stage egg chambers and was proven separately in the follicle cells of late-stage egg chambers by RT-PCR [27,28]. However, since neither dNox nor dSod3 antibodies have been available, the localization of these enzymes in Drosophila ovary is still unclear.
In the current study, we first focused on the localization of dNox and dSod3 in Drosophila ovaries using immunofluorescence. We generated a specific dNox antibody and tested an available SOD3 antibody. We showed that dNox and dSod3 both localize at the follicular epithel of mid- to late-stage egg chambers and that dSod3 localizes to ovariole muscle sheaths and oviducts. Then, we analyzed ovaries in the genetically background of a dsod3 mutant line and knocked down dnox and dsod3 according to the discovered localization. The knockdown experiments revealed severe defects in egg laying that have not been described previously.

2. Results

Localization of dNox and dSod3 in Drosophila Ovaries

The abundance of dNox in Drosophila ovaries has not been tested so far, as a dNox antibody was not available. In order to investigate this task, we generated an antibody against the C-terminal domain of the transmembrane protein dNox (Figure 1, A). To avoid a cross reaction of the antibody with the second member of the Drosophila NADPH oxidase family, the dual specific NADPH oxidase (dDuox), we ensured that amino acid sequences of dNox and dDuox are not conserved, especially at the C-terminal end (Figure 1, C).
As can be seen in Figure 1, A, homogenates of wildtype ovaries show a double band, which was also seen with other NOX-antibodies in other species [35] and might be representative for the second isoform that is described for dNox.
The localization of dSod3 has so far been described in the extracellular space using the Drosophila SL2 cell line [24] and overexpressing a HA-tagged dSod3 construct, secreted into the extracellular space of mature follicles cells [28]. However, due to the lack of a dSod3 antibody suitable for immunohistochemical experiments, the concrete localization of dSod3 has been unknown. In this work, we tested an antibody, that was originally made against human superoxide dismutase 3 (hSOD3), to detect the Drosophila superoxide dismutase 3 (dSod3). First, we aligned and compared amino acid sequences of hSOD3, mouse superoxide dismutase (mSod3) and dSod3 (Figure 1, D). We found a commercially available antibody against hSOD3 that showed a grade of conservation in the amino acid sequence with dSod3 and at the same time low conservation with the remaining isoforms dSod1 and dSod2. Consequently, we decided to test whether we can detect dSod3 specifically (Figure 1, B). The two bands of dSod3 detection are a known phenomenon [24], the upper band nearly reaches the expected molecular weight of about 19 kDa. All together, we were able to generate an antibody against the C-terminal domain of dNox and we found an antibody against the catalytic domain of dSod3.
To localize dNox and dSod3 in adult ovaries, we dissected ovaries from adult females and performed indirect immunostaining on fixed tissue. The localization was checked in all stages of egg chamber development, from germarium to mature follicles and additionally in the oviduct. The most noticeable and representative regions during egg chamber development are shown in Figure 2.
Besides in the ovariole epithelial muscle sheath, both enzymes share a similar protein localization pattern within the developing egg chambers. While dNox shows slight signals in the follicle cells of early egg chambers, dSod3 is expressed in the ovariole muscle sheath, that envelops each single ovariole (Figure 2, A left and right panels; see also Figure S1). From the onset of oocyte growth (at egg chamber stage 7/8, not shown) and even more prominently at stage 10B, dNox and dSod3 are both spatially associated with the tricellular contact regions visible between the main body follicular cells (Figure 2, B arrowhead; see also Figure S2), which form a monolayer covering the growing oocyte. The distribution of dNox and dSod3 appears in spots at these regions. In late-stage egg chambers dNox and dSod3 are mainly found at the anterior end of the mature eggs, surrounding the micropyle and operculum area (Figure 2, C, arrowheads) and, to a much lesser content, at the follicular epithelium, surrounding the mature egg (stage 14).
As previous studies have shown that the ovulation process depends on proper dNox function [28,34], we also investigated the oviduct region of the ovary for potential dNox and dSod3 presence (Figure 3).
Within the oviduct region of the ovary, dNox was detected in the corpus luteum (CL), and to a low content, in the common and the lateral oviduct (Figure 3, A; see also Figure S2 and Figure S3). dSod3 is localized in the muscle layer of the common as well as the lateral oviduct (Figure 3, B and C; see also Figure S1).
Taken together, both proteins share a similar spatio-temporal distribution pattern in the follicular epithel of developing mid- to late-stage egg chambers. Furthermore, the ovarian muscle tissue appears as a prominent region for dSod3 distribution. We found dSod3 at the epithelial muscle sheath, a thin circular layer that is surrounding every single ovariole and at the lateral and common oviduct musculature, which represents a circular layer of somatic muscles.
dNox and dSod3 Are Involved in Egg Laying and/or Egg Hardening Processes
To analyze the in vivo function of dNox and dSod3 in ovaries, we used the hypomorph mutant line, dsod3KG06029 (dsod3KG) and additionally knocked down dnox or dsod3 expression ubiquitously as well as specifically in the follicle epithel of the developing egg chambers using the Gal4/UAS-RNA interference (RNAi) system. For the RNAi experiments two different driver lines, actGal4 (expresses ubiquitously) and OvGal4 (expresses specifically in follicle cells covering the developing oocyte) were used and two independent RNAi lines each for dsod3 (dsod3R1 and dsod3R2) and dnox (dnoxR1 and dnoxR2), respectively (see more tested ovarian specific driver lines in Figure S4). As control, w1118 (+/+) females were used. We examined female abdominal morphology, ovarian morphology, egg morphology, egg laying rate, and hatching rate of either heterozygous (+/dsod3KG) or homozygous (dsod3KG/ dsod3KG) individuals and of females with either ubiquitous or ovarian specific downregulated dsod3 (Figure 4).
As can be seen in Figure 4, A-C, the abdomen of the heterozygous (+/dsod3KG) and homozygous mutant (dsod3KG/dsod3KG) are enlarged when compared to the control (+/+). The same tendency can be seen in the morphology of the dissected ovaries (Figure 4, A’-C’). Both mutants contain a higher number of mature egg chamber stages than the control. The morphology of the laid eggs does not show any obvious differences to the control (Figure 4, A’’-C’’). Similarly, females with ubiquitously or ovarian specific downregulated dsod3 (Figure 4, E and F) show enlarged abdomen compared to control (Figure 4, D). This can be seen even more clearly in the morphology of the ovaries (Figure 4, E’,F’). Females with downregulated dsod3 contain a higher number of mature egg chamber stages in their ovaries compared to control. The tendencies were reproduced with the second dsod3-RNAi line (see supplementary Figure S5). Interestingly, the egg laying rate of the dsod3KG mutants was significantly different. While heterozygous (+/dsod3KG) females laid down nearly as many eggs per 24 hours as control females, egg laying ability of homozygous (dsod3KG/dsod3KG) females was lowered by about 50 % (Figure 4, G). Furthermore, the hatching rate of the eggs laid by homozygous (dsod3KG/dsod3KG) females was significantly reduced by about 40 %, compared to eggs laid by a heterozygous or a control female (Figure 4, I).
RNAi knockdown of dsod3 diminished the egg laying rate by about 30-40 %, independent of ubiquitous or ovarian specific downregulation (Figure 4, H), while the hatching rate was not markedly affected when dsod3 was RNAi downregulated (Figure 4, J).
In summary, we could show that a diminished level of dsod3 expression is connected to a lowered egg laying rate. The observation that ovarian specific RNAi knockdown of dsod3 can impair the egg laying process reveals an ovarian specific function for dSod3 at the follicular epithel.
Using downregulation of dNox by RNA interference, we also analyzed the impact of dNox on ovarian tissue. As for dsod3, we investigated female abdominal morphology, ovarian morphology, egg laying rate, egg morphology and hatching rate of either females with ubiquitous downregulated dnox (actGal4/dnoxR2) or ovarian specific downregulated dnox (OvGal4/dnoxR2) (Figure 5).
As can be seen in Figure 5, both, the abdomen of females with ubiquitously downregulated dnox (Figure 5, B), and with ovarian specific downregulated dnox (Figure 5, D) is enlarged compared to the controls (Figure 5, A and C, respectively). The same differences can be seen in the morphology of the ovaries. Females with downregulated dnox (Figure 5; B’, D’) show enlarged ovaries compared to their controls (Figure 5, A’ and C’). Interestingly, in contrary to the eggs laid by females with downregulated dsod3, a diminished dnox causes significant morphological differences of the eggs. Eggs laid by females with downregulated dnox (Figure 5, B’’ and D’’) have an mis-/underdeveloped chorion structure or even no chorion at all, while empty chorion particles could be found in proximity of the chorion-lacking eggs. The same results were obtained with second dnox-RNAi line (see Figure S5).
The egg laying rate of females with downregulated dnox is different. While control females (actGal4/+ or OvGal4/+) lay about 50-60 eggs per 24 hours, females with downregulated dnox lay about 10-20 eggs during the same time frame (Figure 5, E). Furthermore, the hatching rate of the eggs laid by dnox downregulated females is nearly depleted (1 %) compared to eggs laid by control females that hatch with a rate about 90 % (Figure 5, F).
Taken together, ubiquitous and ovarian specific downregulation of dnox in main body follicle cells, which cover the growing oocyte, seems to have a significant impact during late egg chamber processing. As dissection of the flies revealed enlarged ovaries with a high number of mature egg chambers when dnox is downregulated by RNAi, we assume that oogenesis until late-stage egg chambers is not affected by dnox knockdown, an observation that enforces earlier results [28]. The morphological inspection of the late-stage eggs in the ovary itself initially provided no evidence of defective development in the final stage of oogenesis, but the peculiar morphology of the laid eggs in the case of dnox downregulation aroused further investigation of the late-stage eggs in the ovary.
Interestingly, we observed a difference of the intrinsic fluorescence signal in chorion structures of mature egg chambers in ovaries with downregulated dnox (Figure 6, C, D). This difference was not detected in chorion structures of mature egg chambers with downregulated dsod3 (Figure 6, A, B).
Both, control ovaries (+/dsod3R1; Figure 6, A) and ovaries with ovarian specific downregulation of dsod3 (OvGal4/dsod3R1; Figure 6, B) show an intrinsic fluorescence signal at the dorsal appendages, a chorionic structure of late-stage egg chambers. Control ovaries without dnox RNAi downregulation (OvGal4/+; Figure 6, C) also have an intrinsic fluorescence signal within chorionic structures of late-stage egg chambers. In contrast, ovaries with downregulation of dnox (Figure 6, D) show no intrinsic fluorescence signal of the respective chorion structures (Figure 6, D, white arrowheads) and an altered yolk structure compared to control (Figure 6, D, unfilled white arrowheads). The yolk of mature eggs in dnox downregulated ovaries seems more granulated compared to the control (Figure 6; C, D).
Taken together, a failure in chorion development, that comes along with a unique yolk structure, may be the possible cause of impaired egg laying and the disturbed chorion structure of the laid eggs. These effects were also observed using alternative ovarian specific driver lines (see Figure S6).
dSod Activity within dsod3KG Ovaries
As shown above, morphology of the ovaries and egg laying behavior is impacted by the dsod3KG mutation. This insertion mutant has been described having effect on dsod3 expression and function, as it has shown negative impact on the overall Cu/Zn-dSod activity in whole fly homogenates [25]. Neither immunostaining using dSod3 antibodies revealed differences of dsod3KG ovaries compared to control, nor an ELISA test on ovary homogenates showed significant differences between the amount of dSod3 in the dsod3KG mutant compared to wildtype control (not shown). Therefore, we concluded, that the cause might not be the amount of dSod3 but the activity of the enzyme. Therefore, we assumed that the analysis of the dSod activity in the ovarian tissue would provide insight into the correlation of amount of active enzyme with the deficiencies in fecundity.
Previous studies estimated total dSod activity of all three dSod isoforms or Cu/Zn-dSod activity (by inactivation of Mn-dSod) from whole adult fly samples [25].
Our goal was to estimate total dSod activity directly in the tissue, and we could show that the dsod3KG mutation has physiological/functional consequences. This assay was realized using homogenates of ovaries (Figure 7, A). By this, we could show a reduced overall dSod activity in the dsod3KG mutant, but it was impossible to differentiate between the dSod isoforms (dSod1-3) and which of the isoforms being relatable for the measured dSod activity.
The relative dSod activity in homogenized ovaries of the dsod3KG mutant is significantly lower compared to the wildtype control (+/+) (Figure 7, A). However, no significant difference in total dSod activity (all three dSod isoforms) could be detected between homozygous (dsod3KG/dsod3KG) and heterozygous (dsod3KG/+) mutant ovaries.
As the dSod3 isoform is predicted extracellularly, we then established a new dSod3 assay, using intact ovaries (Figure 7, B and Figure S5). Doing so, it was possible to determine if ovaries show an extracellular dSod3 activity and to differentiate this activity from the intracellular dSod1 and dSod2 activity measured in homogenates. Focusing on the relative activity of extracellular dSod3, we could see a reduction about 90 % in ovaries from the homozygous (dsod3KG/dsod3KG) mutant compared to control (+/+) (Figure 7, B).

Redox Differences in Ovaries

After having shown that dSod3 activity is significantly reduced in dsod3KG mutant ovaries, we aimed to test changes in relative H2O2 level in whole ovaries and at different stages of individual egg chambers. To obtain information about the endogenous H2O2 level, we utilized a genetically encoded redox sensitive green fluorescent protein 2 sensor (roGFP2), specific for hydrogen peroxide as the roGFP2 is coupled to a microbial H2O2 sensor oxidant receptor peroxidase 1 (Orp1) [36,37]. We crossed homozygous biosensor-transgenic flies (BL67670; with roGFP2-Orp1-H2O2-sensor expressed ubiquitously through the tubulin promoter) with homozygous dsod3KG mutant flies or with wildtype as control. Ovaries of the resulting F1 females (heterozygous for the sensor and for the dsod3KG mutation) were dissected and either measured as whole ovaries in a plate reader-based assay (Figure 8, A) or single egg chambers were dissected and imaged using fluorescence microscopy (Figure 8, B and C).
Ovaries of both genotypes were tested for sensor functionality by determining their responsiveness to exogenous reduction and oxidation by exposure of freshly prepared ovaries to the exogenous reductant (dithiothreitol, DTT), for maximum reduction or exogenous oxidant (diamide, DA), for maximum oxidation of the tissue. Both genotypes showed a similar dynamic range (DR; ratio of Oxmax/Oxred) of about 1.65. Therefore, the dsod3KG mutation seems to have no impact on the functionality of the sensor itself. The reduced gene dose in the heterozygous dsod3KG mutant ovaries (dsod3KG/roGFP2) led to a 14 % decrease in H2O2 levels compared to control ovaries (+/roGFP2) (Figure 8, A).
Similar significant difference of about 14 % was also given in each stage of the analyzed individual egg chambers (Figure 8, B). Interestingly, late-stage egg chambers (stage 14) showed a two to three-fold higher H2O2 level compared to earlier stages. In single egg chambers, DR was about 2.14 (+/roGFP2) and 2.69 (dsod3KG/roGFP2). The area that was considered for redox measurement within a single egg chamber always excluded the yolk, as can be seen in the ratio image (Figure 8, C). This was necessary, as with the given excitation wavelength, the intrinsic fluorescence of the yolk would have led to incorrect results. Therefore, we focused on H2O2 levels within the follicular epithel around the growing oocyte and the nutrient cells. Taken together, the H2O2 levels intrinsically increase within late-stage egg chambers and a reduced dsod3 gene dose in dsod3KG mutants relates to reduced H2O2 levels within the above-mentioned areas.

3. Discussion

The development of human ovarian dysfunctions like endometriosis, polycystic ovary syndrome (PCOS) oocyte stress/aging and unexplained infertility is often directly associated with an imbalance between oxidants and antioxidants [38,39]. However, due to ethical and practical obstacles, it is difficult to learn adequately about both, the physiological role of ROS and the pathological development processes associated with oxidative stress during human reproduction. Over the last decade Drosophila has been used successfully as model organism in the context of ovarian (mis)functions [18,40,41,42]. Genes involved in Drosophila ovarian function have remained highly conserved throughout evolution [43] and even cellular organization and oocyte development show similarities [18].
In this study, the impact of the ROS-producing NADPH oxidases (NOX/dNox) and the antioxidative extracellular superoxide dismutases (EC-SOD/dSod3) on the ovarian function was analyzed.
The Drosophila NADPH oxidase (dNox) represents the orthologue to the human NOX5. The function of NOX proteins in the human female reproductive organs is still unclear, but NOX4 and NOX5 proteins were shown to be localized in the human ovary [44,45,46] and were described in human granulosa cells by RT-PCR [47].
Previous studies narrowed down the localization of Drosophila dNox indirectly to the plasma membrane of follicle cells in mature egg chambers (stage 14) [28] and single-cell RNA sequencing identified dNox expression in follicle cells [48].
Our results agree with previous RNA sequencing data and expand the preliminary localization of previous studies to a more widespread localization of dNox in the follicular epithelium of developing mid to late egg chambers.
We further show that ubiquitous or ovarian specific downregulation of dNox in the follicular epithelium leads to a diminished number of laid eggs and rough chorionic defects resulting in a non-viable progeny. Reduced egg laying and ovulation rate has been described before [28,34], but none of the previous studies reported chorionic defects or a diminished hatching rate. Instead, Ritsick et al. describe that eggs laid by tubulinPGal4>UASdnox-RNAi females have normal hatching rates and are fully viable [34]. We therefore tested additional driver lines to see whether they had an influence on the hatching (see Table S1). Except for slboGal4 (BL6458), all ovarian specific driver lines and the ubiquitous driver line actGal4 (BL3954) led to an extremely reduced laying rate and a disabled hatching with non-viable progeny. These results suggest that the function of dNox in follicular cells surrounding the maturing oocyte is essential. In contrast to previous studies, in which eggs of the final stage of maturity were dissected from the ovary and subjected to a rupture test in vitro [28], we observed significant damage to the entire chorion of naturally laid eggs. In addition, we were able to detect differences in the chorion structure of late-stage egg chambers in prepared but still intact ovaries.
We also tested 47A04Gal4 (BL50286), the driver line that was used in previous studies to knockdown dnox in follicle cells of only mature late-stage-14 egg chambers [28]. This knockdown led to a reduced in vitro follicle rupture of dissected eggs. In contrast, our experiments to knockdown dnox with this driver line showed no morphologic changes of the ovaries (see Figure S3 and Figure S6), only a slightly reduced egg laying, and no morphologically impacted eggs (not shown). This might be due to the experimental conditions, as Li et al. performed all RNAi knockdown experiments under amplifying conditions at 29 °C and with co-expression of additional Dicer2 (dcr2) protein [28]. All our dnox RNAi knockdown experiments were performed at 25 °C. Additionally, all ovary-specific driver lines we used targeted follicle cells in a broader range, from early to mid-stage egg chambers. Therefore, we believe that we revealed dNox functions at earlier stages, because stronger effects occurred this way. This is consistent with our localization results of dNox in the mid-stage egg chamber stages as well.
Considering dNox producing superoxide anions (O2●-) to the extracellular space, the loss of these reactive oxygen species (in case of the dNox downregulation) may cause the above-mentioned morphological consequences on the entire chorion structure. Otherwise, the superoxide anions may usually be involved in further reactions, leading to molecules like peroxynitrite (ONOO-) or hydrogen peroxide (H2O2) [49].
The appearance of hydrogen peroxide in Drosophila egg chambers has been described at the end of the eggshell assembly, where it is supposed to be the natural trigger of the peroxidase (Pxd)-catalyzed chorion protein crosslinking [50,51,52]. By this hardening process the chorion becomes insoluble and able to protect the laid egg from desiccation. The source of the needed hydrogen peroxide is not fully understood, as it has already been proven chemically, but the biological source has never been precisely named [53,54]. We suppose that the missing source of hydrogen peroxide might be the dNox-produced superoxide anions which might be dismutated by extracellular dSod3 to hydrogen peroxide. Therefore, the lack of superoxide anions, due to dnox knockdown, could lead to morphological changes in the chorion, such as we observed.
The localization of the Pxd is described mainly in the respiratory filaments, in the micropyle area and to a lower content in the chorion structure of stage 14 follicles [51], matching to the localization of dNox and dSod3 we found in this work. Additionally, in previous studies the use of a peroxidase inhibitor suppressed egg laying which resulted in chorions that were cracked during egg delivery [55] similar to the observations in our work.
Furthermore, since the reduced H2O2 level we proved within the egg chambers of the dsod3KG mutant and the RNAi-knockdown of dsod3 did not result in chorionic defects, as they were observed when dnox is knocked down, we assume that an epistatic event occurs here. Depletion of dnox, the source of superoxide anions that are the substrate for dSod3, may have a greater effect on lowering H2O2 levels than mutation/depletion of dsod3. As long as superoxide anions are still produced by dNox, they can dismutate spontaneously or are dismutated sufficiently, even with a reduced dSod3 function. However, we have not yet been able to measure the H2O2 level in dnox knockdown ovaries, as co-expression of both constructs (roGFP2-sensor and UAS-dnoxRNAi) led to lethality.
Extracellular hydrogen peroxide production was also described to be a critical step for the in vitro follicle rupture [28]. Within the follicle rupture process, extracellular dSod3 was suggested to convert dNox-produced superoxide to hydrogen peroxide, but it remained unclear whether hydrogen peroxide acts extracellularly or diffuses through the cell membrane to reach targets for follicle rupture [28]. Since the roGFP2 sensor used in our study is expressed cytoplasmically, the observed reduction in hydrogen peroxide level (in dsod3KG mutants) should be attributed to the cytoplasm, suggesting that the hydrogen peroxide has at least partially penetrated the corresponding cells. However, this does not rule out that the hydrogen peroxide produced extracellularly does not have extracellular functions.
The Drosophila superoxide dismutase 3 (dSod3) represents the orthologue to the human SOD3 or EC-SOD. High expression of human Cu/Zn-SOD was detected in granulosa cells and theca interna cells of antral and dominant follicles as well as in luteinized granulosa and theca cells of functioning corpora lutea [7,15,56], while extracellular SOD3/EC-SOD was shown in bovine cumulus cells and in cultured cumulus cell/oocyte-complexes (COC), where it is the only SOD isoform that can be detected in the zona pellucida [57]. EC-SOD was also shown to be a critical regulator of the COC’s extracellular matrix (ECM) [12,58]. Due to the lack useful antibodies, few is known about localization of dSod3 in the reproductive tract of Drosophila: the dsod3 expression is elevated in ovaries [26], it has been shown that dSod3 is enriched in late-stage egg chambers [27] and overexpression of dSod3-HA in follicle cells led to the assumption of an extracellular localization of dSod3 in the flies’ ovaries [28].
Our results show a localization of dSod3 in the follicular epithelium of developing egg chambers, in the epithelial muscle-sheath of the ovarioles and in the muscle layer of the oviduct. Accordingly, there is a similar localization of both enzymes in the mammalian granulosa cells/in the zona pellucida, which in Drosophila corresponds to the follicular cells/the space between the follicular cells and the egg cell. The localization of dSod3 at muscle sheaths might represent the predicted membrane-bound isoform [25] and may correspond to the smooth muscle cells associated SOD3 [59].
Previous studies described a dNox depletion-associated inhibition of muscle contractions in the ovaries [34], which led us to suggest a spatial cooperation of dNox and dSod3 may play a role within the muscle sheaths. Our localization experiments revealed that both enzymes are present in the oviduct. As the ovulation rate was markedly lower in dnox RNAi females, previous studies concluded a defective movement of the egg from ovary into oviducts and showed markedly attenuated muscle contractions in dnox depleted ovaries [34]. The muscles surrounding the gut and gonads are functionally analogous to vertebrate smooth muscle [60]. There are three muscle types in the ovary: the peritoneal sheath surrounding each of the two intact ovaries, and the epithelial sheath, thin circular muscle that surround each of the approximately 16 ovarioles, both derive from mesodermal cells. Lateral oviducts, that fuse into the common oviduct through wich mature eggs pass to enter the uterus, are surrounded by a circular layer of somatic muscles [60].
The precise mechanisms inducing muscle contraction and relaxation in the Drosophila ovaries are not known, but previous studies show that both processes are regulated by octopamine via two receptors, OAMB and Octß2R, that are expressed in the epithelia underneath the muscle layer of the entire oviduct [61] and the follicle cells surrounding the devloping egg [62]. Octopamine/OAMB induces a rise in intracellular Ca2+ in these cells [61,62,63]. Octopamine/OAMB-Ca2+ is then able to activate dNox to produce superoxide anions to the extracellular space [28]. The role of dNox derived superoxide anions is still not clear. Getting dismutated to hydrogen peroxide they may be important for the rupturation process, as stated in [28]. However, superoxide anions might also have impact on contraction or relaxion processes in the oviduct muscles. A role for Ca2+-sensitive NOX5 in redox regulation of smooth muscle contraction has been shown [64].
Assuming the smooth-like muscles of the oviduct are sensitive for nitric oxide (NO●) signaling, extracellular dSod3 activity could regulate the contraction or dilation process by modulation of the dNox produced superoxide ion levels, as they are able to switch off the nitric oxide response [49]. NO-Signaling is known in the mammalian ovarian physiology as it has been demonstrated that the multiple isoenzymes of nitric oxide synthase (NOS) are expressed and localized in the ovary of different species [65,66]. A role for NO was ascribed in the processes of steroidogenesis, folliculogenesis, oocyte meiotic maturation and ovulation [65,67,68]. SODs in mammals are known to modulate the bioavailability of nitric oxide and peroxynitrite (ONOO-) rate at vascular smooth muscles or, hence, in the extracellular space [49,69].
Therefore, superoxide ions, which normally switch off the nitric oxide response, could be overrepresented when dsod3 is downregulated in oviducts, leading to an impaired dilatation of the oviduct musculature. That might impact the contraction/dilation of the lateral or common oviduct, and therefore may block the exit for the mature follicles.
This would be conform the significantly reduced egg laying rate we observed with the dsod3KG mutant and the dsod3 RNAi experiments. However, a role for nitric oxide in the Drosophila reproductive tract has not been described by now. In future experiments, it would be interesting to investigate NO synthase function in Drosophila ovaries.

4. Conclusions

In this study we show that in the female reproductive tissue, the localization of dNox and dSod3 largely corresponds to the localization of the mammalian orthologous NOX5 and EC-SOD. This forms a good basis for exploring the function of the mammalian counterparts using the model organism Drosophila. Our results indicate a collaboration between the two enzymes dNox and dSod3, not only during the egg hardening process, but also during the way of the mature eggs through the oviduct.

5. Materials and Methods

Antibodies

The dNox antibody was generated against a synthesized peptide according to the amino acid sequence of the C-terminal end (aa 1325 to aa 1340). Synthetization of the peptide and immunization process was done at GeneCust Service (Boynes, France). The antigen region can be found in all annotated isoforms of dNox (dNox-PB, -PC, -PD and -PE), making the antibody detecting all of them. Cross-reaction of the antibody with the second (dual specific) NADPH oxidase (dDuox) was avoided by checking amino acid sequences with alignments and by blast.

Immunoblotting and Immunostaining

For western blotting analyses, ovaries were freshly prepared in ice-cold phosphate buffered saline (1X PBS: 137 mM NaCl, 2.7 mM KCl, 2 mM KH2PO4, 1.8 mM Na2HPO4·2H2O), transferred to homogenization buffer (1X PBS with 1 % sodiumdodecylsulfate (SDS) and manually homogenized with a pistil on ice and an additional 3X10 sec sonification step (5 ovaries per 200 µl). Loading buffer was added to the homogenates and probes were boiled at 95°C. Afterwards, probes were separated on SDS-polyacrylamide gel electrophoresis (PAGE) and blotted on nitrocellulose membrane. Blocking was done with 5 % skimmed milk powder. For immunoblotting, the dNox antibody (1:250; this work), dSod3 antibody (1:250; Invitrogen #PA5-102904) and α-Tubulin antibody (1:4000; Sigma #6144) were used and detected with peroxidase conjugated secondary anti-rabbit (Sigma; #A0545) or anti-mouse (Sigma; #A9044) antibody (1:20.000) and ECL western blotting substrate (Thermo ScientificTM PierceTM; #32106). Incubation with primary antibody was performed over night at 8 °C, secondary antibodies for 2 h at room temperature (RT).
For immunostaining, ovaries were freshly prepared in ice-cold 1X PBS, fixed with 4 % paraformaldehyde (PFA) for 1h at RT, rinsed in high salted 1X PBShs (500 mM NaCl, 2.7 mM KCl, 1.8 mM KH2PO4, 10.1 mM Na2HPO4·2H2O), washed repeatedly in 1X PBShs with 0.5 % Tween 20 (1X PBSThs) and blocked with 1XPBSThs with 5 % fetal calf serum (FCS) for 30 min at RT. For immunostaining, the dNox antibody (1:500; this work), dSod3 antibody (1:500; Invitrogen #PA5-102904) were used and detected with fluorophore (CyTM3 or CYTM5) conjugated secondary anti-rabbit antibodies (1:500; Jackson Immunoresearch #111-165-003 and #111-175-003). Incubation with primary antibody was performed over night at 8 °C secondary antibodies for 2 h at RT.

Fly Strains

Strains obtained from the Bloomington Drosophila Stock Centre (BDSC; given with BL number) or Vienna Drosophila Research Centre (VDRC; given with VDRC ID number) are: dsod3KG06029 (BL14138); UAS-dsod3R1 (VDRC8760); UAS-dsod3R2 (VDRC37793); UAS-dnoxR1 (BL32433); UAS-dnoxR2 (BL32902); actGal4 (BL3954); OvGal4 (BL3750; also known as “c355Gal4”); slboGal4 (BL6458); CY2Gal4 (BL93734); GR1Gal4 (BL36287); 47A04Gal4 (BL50286; enhancer trap line from janelia campus); w1118 (BL5905); YW (BL6599); tub-cyto-roGFP2-Orp1 (BL67670; [37]); CRIMIC-dnoxGal4 (BL78988); UAS-mCD8-cherryRFP (BL27392)

Egg Laying/Egg Hatching Analysis

To get females with the required genotype crossings were done by putting equal amounts of male and female flies of the same age together and keeping them in vials under standard conditions (25 °C; 65 % humidity; 12/12 dark light cycle). Resulting virgin F1 females were separated and backcrossed with equal amounts of males from the control strain (w1118 or YW). Backcrosses (n=3 for each genotype) were kept in egg laying cups for up to 5 days at standard conditions, holding apple juice agar plates with equal amounts of yeast paste that were changed twice in every 24 h. Since the flies need an acclimatization period until a constant egg laying rate is reached, the first 24 hours after the crossing were not included in the evaluations. For the evaluation, at least double determinations were carried out for each backcross by counting day 2 (24-48 h after crossing) and day 3 (48-72 h after crossing). Laid eggs on each plate were counted to estimate the egg laying rate per female in 24 h of each genotype, then the plates were kept another 24-72 hours at standard conditions. Hatched larvae on each plate were counted to estimate the hatching rate of each analyzed genotype. Female flies from the egg laying cups were documented for abdominal morphology and subsequently prepared ovaries were documented for ovarian morphology. Eggs were photographed on apple juice agar plates, to document egg morphology. All images were taken with the help of a binocular and a Canon EOS-RP camera under consistent conditions.

dSod Activity Assay/dSod3 Activity Assay

Total dSod activity in ovarian tissue was examined using a modified Sod activity assay based on [70]. For each sample, five freshly dissected ovaries were manually homogenized and dissolved in 350 µl phosphate buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 2 mM KH2PO4, 1.8 mM Na2HPO4·2H2O) followed by a serial dilution. Each well of a 96-well plate was preloaded with 110 µl reaction solution (PBS containing 100 µM hypoxanthine and 300 µM water-soluble tetrazolium salt (WST-1)). In each preloaded well 70 µl of a sample dilution were added, before starting the enzymatic reaction by adding 20 µl xanthine oxidase (0.0125 U/ml) per well.
As superoxide anions are produced when hypoxanthine is degraded by the xanthine oxidase, the WST-1 is transformed into WST-1-formazan, which is a yellow dye that can be detected by optical density measurement in a plate reader. The higher the total dSod activity in the samples, the lower the production of WST-1-formazan. Measurements were performed in 96-well plates with the Spark multimode microplate reader (Tecan Group) at a wavelength of 450 nm using 620 nm as reference and at 25 °C. Since ovaries of the three genotypes differ in size, the dSod activity per amount of protein was determined. For this, a BCA protein quantification (ThermoFisher Scientific; PierceTM BCA Protein Assay Kit, #23225) in duplicates of each sample dilution was done separately.
Furthermore, we established a modified dSod3 activity assay to be able to distinguish between intra- and extracellular dSod activity. Each assay was carried out measuring the activity of the extracellular dSod3 of a single intact ovary per well. Each well was preloaded with 188 µl reaction solution (Drosophila saline (DS; 130 mM NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 5 mM HEPES, 36 mM sucrose, 5 mM glucose; pH 7.0 at 25 °C) containing 100 µM hypoxanthine and 300 µM water-soluble tetrazolium salt (WST-1)). To start the reaction, 12 µl of xanthine oxidase (0.05 U/ml) was added per well and measurement was immediately started. Readings were taken every minute for 5 minutes without ovaries to get the basal activity of the added xanthine oxidase. After 5 minutes, freshly in Drosophila saline dissected intact ovaries were added (one per well). The higher the extracellular dSod3 activity of an ovary, the more inhibition of WST-1-formazan production (see also Figure S5). As control, wells without added ovary were measured (getting the dynamic/curve of an unhindered WST-1-formazan production). Measurements were continued immediately (per minute) for 5 more minutes. Subsequently, ovaries were removed from the wells and measurements were continued (per minute) for 5 more minutes. The evolution of the optical density was established graphically and the relative extracellular enzyme activity of dSod3 could be determined.

H2O2 Sensor Measurements

H2O2-levels in whole ovaries and in different stages of single egg chambers were observed by using transgenic flies ubiquitously expressing a genetically encoded roGFP2-Orp1-H2O2-sensor that allows measuring H2O2 (BL67670; [37]).
For the measurement in whole ovaries, a 96-well plate (dark, conical bottom) was prepared by adding 50 µl PBS per well. Freshly in phosphate buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 2 mM KH2PO4, 1.8 mM Na2HPO4·2H2O) dissected ovaries were placed at the bottom into the center of the wells (one per well). Measurement was started immediately. Fluorescence was excited sequentially at 405 and 490 nm, emission detected at 500-560 nm. Calibration was done with the same ovaries, fully reduced by adding dithiothreitol (DTT) to a final concentration of 2 mM or fully oxidized by adding diamide (DA) to a final concentration of 0.5 mM. Measurement was restarted immediately. Maximum reduction was reached after 5 minutes, maximum oxidation was reached after 10 min. Ratio values were calculated by the division of the 405 nm value by the 490 nm value. Dynamic range (DR) was calculated by the division: ratio of maximum oxidation/ratio of maximum reduction
For the measurement of single egg chambers, a sealing ring (ø 10/6 mm), fixed on a coverslip was prefilled with 50 µl 1X PBS. Ovaries were dissected in 1X PBS and staged egg chambers were transferred into the sealing ring and imaged immediately. Calibration was done with the same egg chambers, now fully reduced by adding dithiothreitol (DTT) to a final concentration of 2 mM or fully oxidized by adding diamide (DA) to a final concentration of 0.5 mM. Measurement was restarted immediately. Maximum reduction was reached after 5 minutes, maximum oxidation was reached after 10 min. Imaging was done using an inverse epifluorescence microscope (Axiovert 200M, Carl Zeiss) with CoolLED pE-4000 light source, ORCA-fusion camera (Hamamatsu) and Slidebook6 (3i) imaging software. Fluorescence was excited sequentially at 405 and 470 nm and detected at 500-550 nm (HQ 525/50 nm bandpass). Images were saved and exported as 16-bit tiff files and further processed in ImageJ. Paired 405 nm and 470 nm images were put into a stack. Yolk area was subtracted in both images using the 405 nm image with a matching threshold, creating a region of interest (ROI) that could be deleted in both images. Afterwards, the intensities of the 490 nm image were thresholded and values below this threshold were set to “not a number” (NaN). Values of each channel were obtained using “multi measure” and copied to microsoft excel. Values were calculated as ratio (405/490 nm). The ratio image was created by subtracting background with “rolling ball” set to 150 pixels, dividing the 405 nm image by the 490 nm image pixel by pixel and false coloring with lookup table “fire”. All images were taken with the same microscope settings.

Supplementary Materials

The following supporting information can be downloaded at: www.mdpi.com/xxx/s1, Figure S1: dSod3 localization in oviduct and ovariole muscle sheath; Figure S2: dNox localization in corpus luteum (CL) and follicle cells of mid-stage egg chamber; Figure S3: dnox expression in lateral and common oviduct of Drosophila ovaries; Figure S4: dnox RNAi knockdown with alternative driver; Figure S5: dnox RNAi knockdown with alternative effector lines; Figure S6: Chorion dysmorphology in dnox downregulated ovaries using alternative effector lines.

Author Contributions

Conceiving and designing the experiments: E.L.S. Performing the experiments: E.L.S., A.S. and C.C. Analyzing the data: E.L.S., A.S. and C.C. Writing the paper: E.L.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We thank the following people and facilities: the Bloomington Drosophila Stock Center (NIH P40OD018537) and the Vienna Drosophila Research Center for fly strains used in this study. Furthermore, we thank M. Schwarz for the technical assistance.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. D’Autréaux, B.; Toledano, M.B. ROS as Signalling Molecules: Mechanisms That Generate Specificity in ROS Homeostasis. Nat Rev Mol Cell Biol 2007, 8, 813–824. [Google Scholar] [CrossRef]
  2. Finkel, T. Signal Transduction by Reactive Oxygen Species. Journal of Cell Biology 2011, 194, 7–15. [Google Scholar] [CrossRef]
  3. Sies, H.; Belousov, V. V.; Chandel, N.S.; Davies, M.J.; Jones, D.P.; Mann, G.E.; Murphy, M.P.; Yamamoto, M.; Winterbourn, C. Defining Roles of Specific Reactive Oxygen Species (ROS) in Cell Biology and Physiology. Nat Rev Mol Cell Biol 2022, 23, 499–515. [Google Scholar] [CrossRef] [PubMed]
  4. Sies, H.; Jones, D.P. Reactive Oxygen Species (ROS) as Pleiotropic Physiological Signalling Agents. Nat Rev Mol Cell Biol 2020, 21, 363–383. [Google Scholar] [CrossRef]
  5. Sugino, N. Reactive Oxygen Species in Ovarian Physiology; 2005; Vol. 4;
  6. Shkolnik, K.; Tadmor, A.; Ben-Dor, S.; Nevo, N.; Galiani, D.; Dekel, N. Reactive Oxygen Species Are Indispensable in Ovulation. Proc Natl Acad Sci U S A 2011, 108, 1462–1467. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, S.; He, G.; Chen, M.; Zuo, T.; Xu, W.; Liu, X. The Role of Antioxidant Enzymes in the Ovaries. Oxid Med Cell Longev 2017, 2017. [Google Scholar] [CrossRef] [PubMed]
  8. Liang, J.; Gao, Y.; Feng, Z.; Zhang, B.; Na, Z.; Li, D. Reactive Oxygen Species and Ovarian Diseases: Antioxidant Strategies. Redox Biol 2023, 62. [Google Scholar] [CrossRef]
  9. Rizzo, A.; Roscino, M.T.; Binetti, F.; Sciorsci, R.L. Roles of Reactive Oxygen Species in Female Reproduction. Reproduction in Domestic Animals 2012, 47, 344–352. [Google Scholar] [CrossRef]
  10. Murphy, M.P.; Bayir, H.; Belousov, V.; Chang, C.J.; Davies, K.J.A.; Davies, M.J.; Dick, T.P.; Finkel, T.; Forman, H.J.; Janssen-Heininger, Y.; et al. Guidelines for Measuring Reactive Oxygen Species and Oxidative Damage in Cells and in Vivo. Nat Metab 2022, 4, 651–662. [Google Scholar] [CrossRef]
  11. Zelko, I.N.; Mariani, T.J.; Folz, R.J. SUPEROXIDE DISMUTASE MULTIGENE FAMILY: A COMPARISON OF THE CuZn-SOD (SOD1), Mn-SOD (SOD2), AND EC-SOD (SOD3) GENE STRUCTURES, EVOLUTION, AND EXPRESSION; 2002.
  12. Fukai, T.; Ushio-Fukai, M. Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases. Antioxid Redox Signal 2011, 15, 1583–1606. [Google Scholar] [CrossRef]
  13. Marklund, S.L. Human Copper-Containing Superoxide Dismutase of High Molecular Weight (Lung/Superoxide Radical/Extracellular Fluids); 1982; Vol. 79;
  14. Marklund, S.L.; Holme, E.; Hellner, L. Superoxide Dismutase in Extracellular Fluids. Clinica Chimica Acta 1982, 126, 41–51. [Google Scholar] [CrossRef] [PubMed]
  15. Matos, L.; Stevenson, D.; Gomes, F.; Silva-carvalho, J.L.; Almeida, H. Superoxide Dismutase Expression in Human Cumulus Oophorus Cells. Mol Hum Reprod 2009, 15, 411–419. [Google Scholar] [CrossRef] [PubMed]
  16. Talat, A.; Satyanarayana, P.; Anand, P. Association of Superoxide Dismutase Level in Women with Polycystic Ovary Syndrome. Journal of Obstetrics and Gynecology of India 2022, 72, 6–12. [Google Scholar] [CrossRef] [PubMed]
  17. Wang, Y.; Branicky, R.; Noë, A.; Hekimi, S. Superoxide Dismutases: Dual Roles in Controlling ROS Damage and Regulating ROS Signaling. Journal of Cell Biology 2018, 217, 1915–1928. [Google Scholar] [CrossRef] [PubMed]
  18. Armstrong, A.R. REPRODUCTION REVIEW Drosophila Melanogaster as a Model for Nutrient Regulation of Ovarian Function. 2020. [CrossRef]
  19. Landis, G.N.; Tower, J. Superoxide Dismutase Evolution and Life Span Regulation. Mech Ageing Dev 2005, 126, 365–379. [Google Scholar] [CrossRef] [PubMed]
  20. Hewitt, O.H.; Degnan, S.M. Distribution and Diversity of ROS-Generating Enzymes across the Animal Kingdom, with a Focus on Sponges (Porifera). BMC Biol 2022, 20. [Google Scholar] [CrossRef] [PubMed]
  21. Phillips, J.P.; Campbellt, S.D.; Michaud, D.; Charbonneaut, M.; Hilliker, A.J. Null Mutation of Copper/Zinc Superoxide Dismutase in Drosophila Confers Hypersensitivity to Paraquat and Reduced Longevity; 1989; Vol. 86;
  22. Duttaroy, A.; Parkes, T.; Emtage, P.; Kirby, K.; Boulianne, G.L.; Wang, X.; Hilliker, A.J.; Phillips, I.P. The Manganese Superoxide Dismutase Gene of Drosophila: Structure, Expression, and Evidence for Regulation by MAP Kinase; Mary Ann Liebert, Inc. Pp, 1997; Vol. 16;
  23. Kirby, K.; Hu, J.; Hilliker, A.J.; Phillips, J.P. RNA Interference-Mediated Silencing of Sod2 in Drosophila Leads to Early Adult-Onset Mortality and Elevated Endogenous Oxidative Stress.
  24. Jung, I.; Kim, T.Y.; Kim-Ha, J. Identification of Drosophila SOD3 and Its Protective Role against Phototoxic Damage to Cells. FEBS Lett 2011, 585, 1973–1978. [Google Scholar] [CrossRef]
  25. Blackney, M.J.; Cox, R.; Shepherd, D.; Parker, J.D. Cloning and Expression Analysis of Drosophila Extracellular Cu Zn Superoxide Dismutase. Biosci Rep 2014, 34, 851–863. [Google Scholar] [CrossRef] [PubMed]
  26. Chintapalli, V.R.; Wang, J.; Dow, J.A.T. Using FlyAtlas to Identify Better Drosophila Melanogaster Models of Human Disease. Nat Genet 2007, 39, 715–720. [Google Scholar] [CrossRef]
  27. Eichhorn, S.W.; Subtelny, A.O.; Kronja, I.; Kwasnieski, J.C.; Orr-Weaver, T.L.; Bartel, D.P. MRNA Poly(A)-Tail Changes Specified by Deadenylation Broadly Reshape Translation in Drosophila Oocytes and Early Embryos. 2016. [CrossRef]
  28. Li, W.; Young, J.F.; Sun, J. NADPH Oxidase-Generated Reactive Oxygen Species in Mature Follicles Are Essential for Drosophila Ovulation. Proc Natl Acad Sci U S A 2018, 115, 776–7770. [Google Scholar] [CrossRef]
  29. Lambeth, J.D. NOX Enzymes and the Biology of Reactive Oxygen. Nat Rev Immunol 2004, 4, 181–189. [Google Scholar] [CrossRef] [PubMed]
  30. Bedard, K.; Krause, K.-H. The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology. 2007. [CrossRef]
  31. Brown, D.I.; Griendling, K.K. Nox Proteins in Signal Transduction. Free Radic Biol Med 2009, 47, 1239–1253. [Google Scholar] [CrossRef] [PubMed]
  32. Bedard, K.; Jaquet, V.; Krause, K.H. NOX5: From Basic Biology to Signaling and Disease. Free Radic Biol Med 2012, 52, 725–734. [Google Scholar] [CrossRef] [PubMed]
  33. Touyz, R.M.; Anagnostopoulou, A.; Rios, F.; Montezano, A.C.; Camargo, L.L. NOX5: Molecular Biology and Pathophysiology. Exp Physiol 2019, 104, 605–616. [Google Scholar] [CrossRef] [PubMed]
  34. Ritsick D; Edens W; Finnerty V; Lambeth D Nox Regulation of Smooth Muscle Contraction. Free Radic Biol Med 2007, 43, 31–38. [CrossRef] [PubMed]
  35. Diebold, B.A.; Wilder, S.G.; De Deken, X.; Meitzler, J.L.; Doroshow, J.H.; McCoy, J.W.; Zhu, Y.; Lambeth, J.D. Guidelines for the Detection of NADPH Oxidases by Immunoblot and RT-QPCR. In Methods in Molecular Biology; Humana Press Inc., 2019; Vol. 1982, pp. 191–229.
  36. Gutscher, M.; Sobotta, M.C.; Wabnitz, G.H.; Ballikaya, S.; Meyer, A.J.; Samstag, Y.; Dick, T.P. Proximity-Based Protein Thiol Oxidation by H2O2-Scavenging Peroxidases. Journal of Biological Chemistry 2009, 284, 31532–31540. [Google Scholar] [CrossRef] [PubMed]
  37. Albrecht, S.C.; Barata, A.G.; Großhans, J.; Teleman, A.A.; Dick, T.P. In Vivo Mapping of Hydrogen Peroxide and Oxidized Glutathione Reveals Chemical and Regional Specificity of Redox Homeostasis. Cell Metab 2011, 14, 819–829. [Google Scholar] [CrossRef] [PubMed]
  38. Agarwal, A.; Gupta, S.; Sharma, R.K. Role of Oxidative Stress in Female Reproduction. Reproductive Biology and Endocrinology 2005, 3. [Google Scholar] [CrossRef]
  39. Agarwal, A.; Gupta, S.; Sekhon, L.; Shah, R. Redox Considerations in Female Reproductive Function and Assisted Reproduction: From Molecular Mechanisms to Health Implications. Antioxid Redox Signal 2008, 10, 1375–1403. [Google Scholar] [CrossRef]
  40. Liu, H.; Li, J.; Chang, X.; He, F.; Ma, J. Modeling Obesity-Associated Ovarian Dysfunction in Drosophila. Nutrients 2022, 14. [Google Scholar] [CrossRef]
  41. Brookheart, R.T.; Duncan, J.G. Drosophila Melanogaster: An Emerging Model of Transgenerational Effects of Maternal Obesity. Mol Cell Endocrinol 2016, 435, 20–28. [Google Scholar] [CrossRef] [PubMed]
  42. Bestetti, I.; Barbieri, C.; Sironi, A.; Specchia, V.; Yatsenko, S.A.; de Donno, M.D.; Caslini, C.; Gentilini, D.; Crippa, M.; Larizza, L.; et al. Targeted Whole Exome Sequencing and Drosophila Modelling to Unveil the Molecular Basis of Primary Ovarian Insufficiency. Human Reproduction 2021, 36, 2975–2991. [Google Scholar] [CrossRef] [PubMed]
  43. Elis, S.; Desmarchais, A.; Cardona, E.; Fouchecourt, S.; Dalbies-Tran, R.; Nguyen, T.; Thermes, V.; Maillard, V.; Papillier, P.; Uzbekova, S.; et al. Genes Involved in Drosophilamelanogaster Ovarian Function Are Highly Conserved throughout Evolution. Genome Biol Evol 2018, 10, 2629–2642. [Google Scholar] [CrossRef] [PubMed]
  44. Buck, T.; Hack, C.T.; Berg, D.; Berg, U.; Kunz, L.; Mayerhofer, A. The NADPH Oxidase 4 Is a Major Source of Hydrogen Peroxide in Human Granulosa-Lutein and Granulosa Tumor Cells. Sci Rep 2019, 9. [Google Scholar] [CrossRef] [PubMed]
  45. Buck, T. Role of ROS and ROS Generating Enzymes in the Human Ovary, 2018.
  46. Szeles, Z.; Petheő, G.L.; Szikora, B.; Kacskovics, I.; Geiszt, M. A Novel Monoclonal Antibody Reveals the Enrichment of NADPH Oxidase 5 in Human Splenic Endothelial Cells. Sci Rep 2023, 13. [Google Scholar] [CrossRef] [PubMed]
  47. Kampfer, C.; Saller, S.; Windschüttl, S.; Berg, D.; Berg, U.; Mayerhofer, A. Pigment-Epithelium Derived Factor (PEDF) and the Human Ovary: A Role in the Generation of ROS in Granulosa Cells. Life Sci 2014, 97, 129–136. [Google Scholar] [CrossRef] [PubMed]
  48. Jevitt, A.; Chatterjee, D.; Xie, G.; Wang, X.F.; Otwell, T.; Huang, Y.C.; Deng, W.M. A Single-Cell Atlas of Adult Drosophila Ovary Identifies Transcriptional Programs and Somatic Cell Lineage Regulating Oogenesis. PLoS Biol 2020, 18. [Google Scholar] [CrossRef] [PubMed]
  49. Piacenza, L.; Zeida, A.; Trujillo, M.; Radi, R. THE SUPEROXIDE RADICAL SWITCH IN THE BIOLOGY OF NITRIC OXIDE AND PEROXYNITRITE. Physiol Rev 2022, 102, 1881–1906. [Google Scholar] [CrossRef]
  50. Mindrinos, M.N.; Petri, W.H.; Galanopoulos, V.K.; Lombard, M.F.; Margaritis, L.H. Crosslinking of the Drosophila Chorion Involves a Peroxidase; 1980; Vol. 189;
  51. Konstandi, O.A.; Papassideri, I.S.; Stravopodis, D.J.; Kenoutis, C.A.; Hasan, Z.; Katsorchis, T.; Wever, R.; Margaritis, L.H. The Enzymatic Component of Drosophila Melanogaster Chorion Is the Pxd Peroxidase. Insect Biochem Mol Biol 2005, 35, 1043–1057. [Google Scholar] [CrossRef]
  52. Keramaris, K.E.; Konstantopoulos, K.; Margaritis, L.H.; Velentzas, A.D.; Papassideri, I.S.; Stravopodis, D.J. Exploitation of Drosophila Choriogenesis Process as a Model Cellular System for Assessment of Compound Toxicity: The Phloroglucinol Paradigm. Sci Rep 2020, 10. [Google Scholar] [CrossRef]
  53. Margaritis, L.H.; Kafatos, F.C.; Petri, W.H. The Eggshell of Drosophila Melanogaster I. Fine Structure of the Layers and Regions of the Wild Type Eggshell. J. Cell Sci 1980, 43, 1–35. [Google Scholar] [CrossRef] [PubMed]
  54. Margaritis L The Eggshell of Drosophila Melanogaster III. Covalent Crosslinking of the Chorion Proteins Involves Endogenous Hydrogen Peroxide. Tissue Cell 1985, 17, 553–559. [Google Scholar] [CrossRef] [PubMed]
  55. Keramaris, K.E.; Margaritis, L.H.; Zografou, E.N.; Tsiropoulos, G.J. Egg Laying Suppression in Drosophila Melanogaster (Diptera: Drosophilidae) and Dacus (Bactrocera) Oleae (Diptera: Tephritidae) by Phloroglucinol, a Peroxidase Inhibitor; 1996; Vol. 86;
  56. Suzuki, T.; Sugino, N.; Fukaya, T.; Sugiyama, S.; Uda, T.; Takaya, R.; Yajima, A.; Sasano, H. Superoxide Dismutase in Normal Cycling Human Ovaries: Immunohistochemical Localization and Characterization, 1999.
  57. Combelles, C.M.H.; Holick, E.A.; Paolella, L.J.; Walker, D.C.; Wu, Q. Profiling of Superoxide Dismutase Isoenzymes in Compartments of the Developing Bovine Antral Follicles. Reproduction 2010, 139, 871–881. [Google Scholar] [CrossRef] [PubMed]
  58. Sah, S.K.; Agrahari, G.; Kim, T.Y. Insights into Superoxide Dismutase 3 in Regulating Biological and Functional Properties of Mesenchymal Stem Cells. Cell Biosci 2020, 10. [Google Scholar] [CrossRef] [PubMed]
  59. Stralin, P.; Karlsson, K.; Johansson, B.O.; Marklund, S.L. The Interstitium of the Human Arterial Wall Contains Very Large Amounts of Extracellular Superoxide Dismutase, 1995.
  60. Hudson, A.M.; Petrella, L.N.; Tanaka, A.J.; Cooley, L.
  61. Deshpande, S.A.; Rohrbach, E.W.; Asuncion, J.D.; Harrigan, J.; Eamani, A.; Schlingmann, E.H.; Suto, D.J.; Lee, P.T.; Schweizer, F.E.; Bellen, H.J.; et al. Regulation of Drosophila Oviduct Muscle Contractility by Octopamine. iScience 2022, 25. [Google Scholar] [CrossRef] [PubMed]
  62. Deady, L.D.; Sun, J. A Follicle Rupture Assay Reveals an Essential Role for Follicular Adrenergic Signaling in Drosophila Ovulation. PLoS Genet 2015, 11. [Google Scholar] [CrossRef] [PubMed]
  63. Deady, L.D.; Shen, W.; Mosure, S.A.; Spradling, A.C.; Sun, J. Matrix Metalloproteinase 2 Is Required for Ovulation and Corpus Luteum Formation in Drosophila. PLoS Genet 2015, 11, 1–15. [Google Scholar] [CrossRef] [PubMed]
  64. Montezano, A.C.; Camargo, L.D.L.; Persson, P.; Rios, F.J.; Harvey, A.P.; Anagnostopoulou, A.; Palacios, R.; Gandara, A.C.P.; Alves-Lopes, R.; Neves, K.B.; et al. NADPH Oxidase 5 Is a Pro-Contractile Nox Isoform and a Point of Cross-Talk for Calcium and Redox Signaling-Implications in Vascular Function. J Am Heart Assoc 2018, 7. [Google Scholar] [CrossRef] [PubMed]
  65. Budani, M.C.; Tiboni, G.M. Novel Insights on the Role of Nitric Oxide in the Ovary: A Review of the Literature. Int J Environ Res Public Health 2021, 18, 1–19. [Google Scholar] [CrossRef]
  66. Zhang, W.; Chen, S. juan; Guo, L. ya; Zhang, Z.; Zhang, J. bin; Wang, X. meng; Meng, X. bo; Zhang, M. ying; Zhang, K. ke; Chen, L. lin; et al. Nitric Oxide Synthase and Its Function in Animal Reproduction: An Update. Front Physiol 2023, 14. [Google Scholar] [CrossRef]
  67. Ekerhovd, E.; Brännström, M.; Alexandersson, M. Evidence for Nitric Oxide Mediation of Contractile Activity in Isolated Strips of the Human Fallopian Tube A.Norström NO Is Highly Unstable, with a Half-Life of Seconds in Buffer; 1997; Vol. 12;
  68. Berisha, B.; Schams, D.; Sinowatz, F.; Rodler, D.; Pfaffl, M.W. Hypoxia-Inducible Factor-1alpha and Nitric Oxide Synthases in Bovine Follicles Close to Ovulation and Early Luteal Angiogenesis. Reproduction in Domestic Animals 2020, 55, 1573–1584. [Google Scholar] [CrossRef] [PubMed]
  69. Fattman, C.L.; Schaefer, L.M.; Oury, T.D. Extracellular Superoxide Dismutase in Biology and Medicine. Free Radic Biol Med 2003, 35, 236–256. [Google Scholar] [CrossRef] [PubMed]
  70. Beauchamp, C.; Fridovich, I. Superoxide Dismutase: Improved Assays and an Assay Applicable to Acrylamide Gels1; 1971; Vol. 44;
  71. Lee, P.-T.; Zirin, J.; Kanca, O.; Lin, W.-W.; Schulze, K.L.; Li-Kroeger, D.; Tao, R.; Devereaux, C.; Hu, Y.; Chung, V.; et al. A Gene-Specific T2A-GAL4 Library for Drosophila. 2018. [CrossRef]
Preprints 104652 g001
Figure 1. Western blot analysis of whole ovary homogenates with A anti-dNox antibody (1:500; this work) and B anti-dSod3 antibody (1:500; #PA5-102904 Invitrogen). Amount of the probes is equivalent to 0.25, 0.5 or 1 ovary; α-Tubulin was used as loading control; probes were run on a 7 % SDS-PAGE when analyzing dNox and on a 12 % SDS-PAGE when analyzing dSod3 (optimized for protein size). C Alignment of the amino acid sequences that were used as immunogen for the generation of the antibody against Drosophila NADPH oxidase (dNox) (black letters) against the amino acid sequence of the second Drosophila (dual specific) NADPH oxidase (dDuox) (in grey) D Alignment of the amino acid sequences of Drosophila superoxide dismutase 3 (dSod3) (black letters), human superoxide dismutase 3 (hSOD3), the mouse superoxide dismutase 3 (mSod3) and the two remaining Drosophila superoxide dismutase isoforms 1 and 2 (dSod2 and dSod2) (in grey). Asterisks mark amino acid residues that are conserved between dSod3, hSOD3 and mSod3.
Figure 1. Western blot analysis of whole ovary homogenates with A anti-dNox antibody (1:500; this work) and B anti-dSod3 antibody (1:500; #PA5-102904 Invitrogen). Amount of the probes is equivalent to 0.25, 0.5 or 1 ovary; α-Tubulin was used as loading control; probes were run on a 7 % SDS-PAGE when analyzing dNox and on a 12 % SDS-PAGE when analyzing dSod3 (optimized for protein size). C Alignment of the amino acid sequences that were used as immunogen for the generation of the antibody against Drosophila NADPH oxidase (dNox) (black letters) against the amino acid sequence of the second Drosophila (dual specific) NADPH oxidase (dDuox) (in grey) D Alignment of the amino acid sequences of Drosophila superoxide dismutase 3 (dSod3) (black letters), human superoxide dismutase 3 (hSOD3), the mouse superoxide dismutase 3 (mSod3) and the two remaining Drosophila superoxide dismutase isoforms 1 and 2 (dSod2 and dSod2) (in grey). Asterisks mark amino acid residues that are conserved between dSod3, hSOD3 and mSod3.
Preprints 104652 g001
Preprints 104652 g002
Figure 2. Comparison of dNox and dSod3 localization by immunohistochemistry A early egg chambers, B stage 10 egg chambers, and C late stages of egg chamber development. A dNox localization (left panel) and dSod3 localization (right panel) in early egg chambers, white arrowheads point to the muscle sheaths surrounding the ovarioles (respective to the black arrowheads in the transmitted light images) B dNox localization (left panel) and dSod3 localization (right panel) in stage 10 egg chambers; focus was set to the follicle cell epithel that surrounds the growing oocyte. Boxes show magnified areas with black arrow heads pointing to tricellular junctions between the follicle cells that surround the oocyte. C dNox localization (left panel) and dSod3 localization (right panel) in the anterior region of late egg chambers; white arrowheads point to the anterior area of the mature egg with the operculum and the micropyle (respective to the black arrowheads in the transmitted light images). All fluorescent images are accompanied by the respective transmitted light (TL) images for a better identification of all structures. Indirect immunostaining was done using anti-dNox (1:250; this work) or anti-dSod3 (1:250; #PA5-102904 Invitrogen) antibody combined with fluorophore coupled (Cy3 or Cy5) secondary antibodies on fixed ovaries.
Figure 2. Comparison of dNox and dSod3 localization by immunohistochemistry A early egg chambers, B stage 10 egg chambers, and C late stages of egg chamber development. A dNox localization (left panel) and dSod3 localization (right panel) in early egg chambers, white arrowheads point to the muscle sheaths surrounding the ovarioles (respective to the black arrowheads in the transmitted light images) B dNox localization (left panel) and dSod3 localization (right panel) in stage 10 egg chambers; focus was set to the follicle cell epithel that surrounds the growing oocyte. Boxes show magnified areas with black arrow heads pointing to tricellular junctions between the follicle cells that surround the oocyte. C dNox localization (left panel) and dSod3 localization (right panel) in the anterior region of late egg chambers; white arrowheads point to the anterior area of the mature egg with the operculum and the micropyle (respective to the black arrowheads in the transmitted light images). All fluorescent images are accompanied by the respective transmitted light (TL) images for a better identification of all structures. Indirect immunostaining was done using anti-dNox (1:250; this work) or anti-dSod3 (1:250; #PA5-102904 Invitrogen) antibody combined with fluorophore coupled (Cy3 or Cy5) secondary antibodies on fixed ovaries.
Preprints 104652 g002
Preprints 104652 g003
Figure 3. dNox and dSod3 localization in the oviduct Oviducts of wildtype females, immunostained with: A, A’ anti-dNox antibody (1:250; this work) and B, B’ anti-dSod3 antibody (1:250; #PA5-102904 Invitrogen) combined with fluorophore coupled secondary antibodies on fixed ovaries. Fluorescent images are accompanied by the respective transmitted light (TL) images for a better identification of all structures. Filled arrowheads point to the common oviduct and unfilled arrowheads depict parts of the lateral oviducts. While A and B show a cross section focus, C shows a magnified and surface focused view from B for a more detailed representation of the dSod3 localization in the common oviduct area. Asterisks in A and A ‘mark a corpus luteum (CL).
Figure 3. dNox and dSod3 localization in the oviduct Oviducts of wildtype females, immunostained with: A, A’ anti-dNox antibody (1:250; this work) and B, B’ anti-dSod3 antibody (1:250; #PA5-102904 Invitrogen) combined with fluorophore coupled secondary antibodies on fixed ovaries. Fluorescent images are accompanied by the respective transmitted light (TL) images for a better identification of all structures. Filled arrowheads point to the common oviduct and unfilled arrowheads depict parts of the lateral oviducts. While A and B show a cross section focus, C shows a magnified and surface focused view from B for a more detailed representation of the dSod3 localization in the common oviduct area. Asterisks in A and A ‘mark a corpus luteum (CL).
Preprints 104652 g003
Preprints 104652 g004
Figure 4. Diminished level of dsod3 has impact on ovary function and egg laying A-F abdominal morphology, A’-F’ ovary morphology, A’’-F’’ laid eggs morphology. First lane: control (+/+) compared to females with diminished gene dose of dsod3: heterozygous mutant (+/dsod3KG) and homozygous mutant (dsod3KG/dsod3KG).Second lane: control without RNAi induction (+/dsod3R2) compared to females with ubiquitously (actGal4/dsod3R2) or ovarian specific (OvGal4/dsod3R2) downregulated dsod3 G,H egg laying rates (per female per 24 h) of different genotypes with diminished dsod3 level (n ≥ 20 females for each genotype) I,J hatching rates of the different genotypes with diminished dsod3 level. Error bars mark standard deviation.
Figure 4. Diminished level of dsod3 has impact on ovary function and egg laying A-F abdominal morphology, A’-F’ ovary morphology, A’’-F’’ laid eggs morphology. First lane: control (+/+) compared to females with diminished gene dose of dsod3: heterozygous mutant (+/dsod3KG) and homozygous mutant (dsod3KG/dsod3KG).Second lane: control without RNAi induction (+/dsod3R2) compared to females with ubiquitously (actGal4/dsod3R2) or ovarian specific (OvGal4/dsod3R2) downregulated dsod3 G,H egg laying rates (per female per 24 h) of different genotypes with diminished dsod3 level (n ≥ 20 females for each genotype) I,J hatching rates of the different genotypes with diminished dsod3 level. Error bars mark standard deviation.
Preprints 104652 g004
Preprints 104652 g005
Figure 5. Diminished level of dnox has impact on ovary function, egg laying and chorion development A-D abdominal morphology is enlarged in females with ubiquitously (actGal4/dnoxR2) or ovarian specific (OvGal4/dnoxR2) downregulated dnox compared to the controls (actGal4/+ and OvGal4/+). A’-D’ Ovaries with ubiquitously (actGal4/dnoxR2) or ovarian specific (OvGal4/dnoxR2) downregulated dnox are enlarged and contain more late-stage egg chambers compared to their controls (actGal4/+ and OvGal4/+). A’’-D’’ Naturally laid eggs from females with ubiquitously (actGal4/dnoxR2) or ovarian specific downregulated dnox (OvGal4/dnoxR2) are smaller and show dysmorphic chorion structures compared to the morphology control (actGal4/+ and OvGal4/+). E, F egg laying rates per female per 24 h of different genotypes with diminished dnox level (n ≥ 25 females for each genotype) I, J hatching rates of the different genotypes with diminished dnox level. Error bars mark standard deviation.
Figure 5. Diminished level of dnox has impact on ovary function, egg laying and chorion development A-D abdominal morphology is enlarged in females with ubiquitously (actGal4/dnoxR2) or ovarian specific (OvGal4/dnoxR2) downregulated dnox compared to the controls (actGal4/+ and OvGal4/+). A’-D’ Ovaries with ubiquitously (actGal4/dnoxR2) or ovarian specific (OvGal4/dnoxR2) downregulated dnox are enlarged and contain more late-stage egg chambers compared to their controls (actGal4/+ and OvGal4/+). A’’-D’’ Naturally laid eggs from females with ubiquitously (actGal4/dnoxR2) or ovarian specific downregulated dnox (OvGal4/dnoxR2) are smaller and show dysmorphic chorion structures compared to the morphology control (actGal4/+ and OvGal4/+). E, F egg laying rates per female per 24 h of different genotypes with diminished dnox level (n ≥ 25 females for each genotype) I, J hatching rates of the different genotypes with diminished dnox level. Error bars mark standard deviation.
Preprints 104652 g005
Preprints 104652 g006
Figure 6. Chorion dysmorphology in dnox downregulated ovaries A control ovary (+/dsod3R1), B ovary with ovarian specific downregulation of dsod3 (OvGal4/dsod3R1) and C control ovary (OvGal4/+) show fluorescence signals at chorion structures (white arrowheads). D ovary with ovarian specific (OvGal4/dnoxR1) downregulation of dnox. All ovaries were tested for intrinsic fluorescence signals after excitation with 470 nm and with GFP-specific emission filter set. White arrowheads point to the dorsal appendages of the chorion, unfilled white arrowheads to the yolk of mature egg chambers. Scale bars 100 µm.
Figure 6. Chorion dysmorphology in dnox downregulated ovaries A control ovary (+/dsod3R1), B ovary with ovarian specific downregulation of dsod3 (OvGal4/dsod3R1) and C control ovary (OvGal4/+) show fluorescence signals at chorion structures (white arrowheads). D ovary with ovarian specific (OvGal4/dnoxR1) downregulation of dnox. All ovaries were tested for intrinsic fluorescence signals after excitation with 470 nm and with GFP-specific emission filter set. White arrowheads point to the dorsal appendages of the chorion, unfilled white arrowheads to the yolk of mature egg chambers. Scale bars 100 µm.
Preprints 104652 g006
Preprints 104652 g007
Figure 7. Total dSod activity compared to extracellular dSod3 activity of Drosophila ovaries A Relative dSod enzyme activity within ovary homogenates of the control (+/+), the heterozygous mutant (+/dsod3KG) and the homozygous mutant (dsod3KG/dsod3KG); n=5 for each genotype; p-value ≤ 0.0001. B Relative extracellular dSod3 activity from intact ovaries of control (+/+) or homozygous mutant (dsod3KG/dsod3KG); n=8 for each genotype; p-value ≤ 0.01. Values are normalized to control, unpaired t-test provided information about significances. n.s. = not significant; * = significant, error bars mark the standard deviation.
Figure 7. Total dSod activity compared to extracellular dSod3 activity of Drosophila ovaries A Relative dSod enzyme activity within ovary homogenates of the control (+/+), the heterozygous mutant (+/dsod3KG) and the homozygous mutant (dsod3KG/dsod3KG); n=5 for each genotype; p-value ≤ 0.0001. B Relative extracellular dSod3 activity from intact ovaries of control (+/+) or homozygous mutant (dsod3KG/dsod3KG); n=8 for each genotype; p-value ≤ 0.01. Values are normalized to control, unpaired t-test provided information about significances. n.s. = not significant; * = significant, error bars mark the standard deviation.
Preprints 104652 g007
Preprints 104652 g008
Figure 8. Endogenous H2O2 level reduced in ovaries of the dsod3KG mutant A Relative H2O2 level in whole ovaries measured by genetically encoded roGFP2-Orp1-H2O2-sensor in a plate reader (n=55 per genotype); DR (dynamic range) of each genotype B Relative H2O2 level in different stages of egg chamber development measured on fluorescent microscope (n>30 for each genotype and egg chamber stage; *, p-value ≤ 0.005; error bars mark standard deviation) C Example of egg chambers expressing the sensor molecule. Fluorescence was excited at 470 nm and at 405 nm and always detected at 500-550 nm. The ratio of both values reveals the oxidation status (and therefore the relative H2O2 level) of the sensor molecule.
Figure 8. Endogenous H2O2 level reduced in ovaries of the dsod3KG mutant A Relative H2O2 level in whole ovaries measured by genetically encoded roGFP2-Orp1-H2O2-sensor in a plate reader (n=55 per genotype); DR (dynamic range) of each genotype B Relative H2O2 level in different stages of egg chamber development measured on fluorescent microscope (n>30 for each genotype and egg chamber stage; *, p-value ≤ 0.005; error bars mark standard deviation) C Example of egg chambers expressing the sensor molecule. Fluorescence was excited at 470 nm and at 405 nm and always detected at 500-550 nm. The ratio of both values reveals the oxidation status (and therefore the relative H2O2 level) of the sensor molecule.
Preprints 104652 g008
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated